Patients & CaregiversHealthcare Professionals - Opens new windowWorldwide - Opens new window
HomeAbout Merck Products Newsroom Investor Information CareersResearchLicensing

The Merck Manual of Health & Aging Logo

Committed to Providing Medical Information

gray rule

Table of Contents

Index

gray rule

Enlarge Text
Reset Text
Shrink Text

gray rule

book   Buy the Book

gray rule Selected Links
 
grey line
INDEX   Index A ~ Index B ~ Index C ~ Index D ~ Index E ~ Index F ~ Index G ~ Index H ~ Index I ~ Index J ~ Index K ~ Index L ~ Index M ~ Index N ~ Index O ~ Index P ~ Index Q ~ Index R ~ Index S ~ Index T ~ Index U ~ Index V ~ Index W ~ Index X ~ Index Y ~ Index Z
grey line
 

Index B

Baclofen: Sec. 3, Ch. 30
Bacteria: (see Infection)
Bacterial overgrowth
diarrhea with: Sec. 3, Ch. 55
Bacteriuria
asymptomatic: Sec. 3, Ch. 56
Balance
aging and: Sec. 3, Ch. 20
problems with: Sec. 1, Ch. 1; Sec. 3, Ch. 20
     falls and: Sec. 3 Ch. 21 [detail]
     in neuropathy: Sec. 3, Ch. 29
     in Parkinson's disease: Sec. 3, Ch. 30
     testing for: Sec. 3, Ch. 20
     testing safety and: Sec. 2, Ch. 10
exercises for: Sec. 2, Ch. 13; Sec. 3, Ch. 60
Balloon dilation
of esophagus: Sec. 3, Ch. 54
Barbiturates: Sec. 2, Ch. 6
medicinal herb interactions with: Sec. 2, Ch. 7
Barium x-ray study
in anemia: Sec. 3, Ch. 49
in constipation: Sec. 3, Ch. 55
in gastroesophageal reflux: Sec. 3, Ch. 54
in swallowing difficulty: Sec. 3, Ch. 54
Barrett's esophagus: Sec. 3, Ch. 54
Bartholin's glands
cancer of: Sec. 3, Ch. 51
Basal cell cancer: Sec. 3, Ch. 51
Basal ganglia: Sec. 3, Ch. 30
     in Parkinson's disease: Sec. 3, Ch. 30
     in progressive supranuclear palsy: Sec. 3, Ch. 30
Bed rest
blood clots and: Sec. 3, Ch. 49
constipation and: Sec. 3, Ch. 55
after fracture: Sec. 3, Ch. 23
muscle strength loss with: Sec. 1, Ch. 2
problems from: Sec. 3, Ch. 23
in rheumatoid arthritis: Sec. 3, Ch. 41
urinary incontinence and: Sec. 2, Ch. 11; Sec. 3, Ch. 57
Bed
air-fluidized: Sec. 3, Ch. 35
adjustment of
     in gastroesophageal reflux: Sec. 3, Ch. 54
transfer from: Sec. 2, Ch. 13
Bedsores: (see Pressure sores)
Behavior
in Alzheimer's disease: Sec. 3, Ch. 27
in dementia: Sec. 3, Ch. 27; Sec. 3, Ch. 27
REM sleep disorder of: Sec. 3, Ch. 31
Belladonna alkaloids: Sec. 2, Ch. 6
Benazepril
in coronary artery disease: Sec. 3, Ch. 45
in heart failure: Sec. 3, Ch. 46
in high blood pressure: Sec. 3, Ch. 43
urinary incontinence with: Sec. 3, Ch. 57
Bence Jones proteins: Sec. 3, Ch. 51
Benign positional vertigo: Sec. 3, Ch. 20; Sec. 3, Ch. 20; Sec. 3, Ch. 20; Sec. 3, Ch. 20
Benign prostatic hyperplasia: Sec. 3, Ch. 59
urinary incontinence and
urinary tract infection with: Sec. 3, Ch. 56
Benign prostatic hyperplasia
saw palmetto effects on: Sec. 2, Ch. 7
Benign senescent forgetfulness: Sec. 3 Ch. 27 [sidebar]
Benzodiazepines: Sec. 2, Ch. 6
alcohol interactions with: Sec. 3 Ch. 32 [sidebar]
in anxiety: Sec. 3, Ch. 32
in delirium: Sec. 3, Ch. 26
in dementia: Sec. 3, Ch. 27
dizziness with: Sec. 3, Ch. 20
in dystonia: Sec. 3, Ch. 30
in insomnia: Sec. 3, Ch. 31
Benztropine: Sec. 3, Ch. 30; Sec. 3, Ch. 30
Berberine: Sec. 2, Ch. 7
Bereavement: Sec. 2, Ch. 16; Sec. 4, Ch. 61
information resources on: 884-885
Beta-blockers
in abnormal heart rhythms: Sec. 3, Ch. 47
in coronary artery disease: Sec. 3, Ch. 45; Sec. 3, Ch. 45
dizziness with: Sec. 3, Ch. 20
fainting with: Sec. 3, Ch. 20
in glaucoma: Sec. 3, Ch. 36
after heart attack: Sec. 3, Ch. 45
in heart failure: Sec. 3, Ch. 46; Sec. 3, Ch. 46
in heart valve disorders: Sec. 3, Ch. 48
in high blood pressure: Sec. 3, Ch. 43; Sec. 3, Ch. 43
in hyperthyroidism: Sec. 3, Ch. 33
in tremor: Sec. 3, Ch. 30
Beta-carotene: Sec. 1 Ch. 1 [sidebar]
Betaxolol
in abnormal heart rhythms: Sec. 3, Ch. 47
in coronary artery disease: Sec. 3, Ch. 45
in heart failure: Sec. 3, Ch. 46
BI-PAP (bilevel positive airway pressure): Sec. 3, Ch. 31
Bicalutamide: Sec. 3, Ch. 51
Bicycling: Sec. 2, Ch. 13
Bifocals: Sec. 1, Ch. 2
Big toe
bunion and: Sec. 3, Ch. 40
gout in: Sec. 3, Ch. 41
Biguanides: Sec. 3, Ch. 34; Sec. 3, Ch. 34
Bile acid binders: Sec. 3, Ch. 44
Bilevel positive airway pressure (BI-PAP): Sec. 3, Ch. 31
Binswanger's disease: Sec. 3, Ch. 27
Bioelectric impedance analysis: Sec. 2, Ch. 5
Bioelectromagnetic therapy: Sec. 2, Ch. 7
Biofeedback
in pain management: Sec. 3, Ch. 24
in tinnitus: Sec. 3, Ch. 37
Biological age: Sec. 1, Ch. 1
Biopsy: Sec. 2, Ch. 10
bone marrow: Sec. 3, Ch. 49 (see also Bone marrow, biopsy of)
breast: Sec. 3, Ch. 51
in cancer: Sec. 3, Ch. 50
endometrium: Sec. 3, Ch. 58
intestinal: Sec. 3, Ch. 51
nerve: Sec. 3, Ch. 29
prostate: Sec. 2, Ch. 10; Sec. 3, Ch. 51
skin: Sec. 2, Ch. 10; Sec. 3, Ch. 35
temporal artery: Sec. 3, Ch. 42
thyroid: Sec. 3, Ch. 33
uterus: Sec. 3, Ch. 58
Bipolar disease: Sec. 3, Ch. 32; Sec. 3, Ch. 32; Sec. 3, Ch. 32
Bisacodyl: Sec. 3, Ch. 55; Sec. 3, Ch. 55
Bismuth: Sec. 3, Ch. 55
Bisoprolol
in abnormal heart rhythms: Sec. 3, Ch. 47
in coronary artery disease: Sec. 3, Ch. 45
in heart failure: Sec. 3, Ch. 46
in high blood pressure: Sec. 3, Ch. 43
Bisphosphonates
esophageal damage with: Sec. 3, Ch. 54
for high calcium levels: Sec. 3, Ch. 18
in multiple myeloma: Sec. 3, Ch. 51
in osteoporosis: Sec. 3, Ch. 22; Sec. 3, Ch. 22
in prostate cancer: Sec. 3, Ch. 51
Bladder: Sec. 3, Ch. 57
aging of: Sec. 1, Ch. 2; Sec. 3, Ch. 57
bulge of (cystocele): Sec. 3, Ch. 56; Sec. 3, Ch. 58; Sec. 3, Ch. 58; Sec. 3, Ch. 57
catheterization of
     in overflow incontinence: Sec. 3, Ch. 57
catheterization: (see Catheter[ization], urinary)
incontinence of: (see Incontinence, urinary)
infection of: Sec. 3, Ch. 56
neurogenic: Sec. 3, Ch. 56
overactive: Sec. 3, Ch. 57; Sec. 3, Ch. 59
Bleeding time: Sec. 3, Ch. 49
Bleeding
anemia with: Sec. 3, Ch. 49; Sec. 3, Ch. 49; Sec. 3, Ch. 49
aspirin and: Sec. 3, Ch. 24
brain: Sec. 3, Ch. 28; Sec. 3, Ch. 28; Sec. 3, Ch. 28
in cancer: Sec. 3, Ch. 50
with cardiac catheterization: Sec. 3, Ch. 45
in disseminated intravascular coagulation: Sec. 3, Ch. 49; Sec. 3, Ch. 49; Sec. 3, Ch. 49
in gastroesophageal reflux: Sec. 3, Ch. 54
in leukemia: Sec. 3, Ch. 50
NSAIDs and: Sec. 3, Ch. 24
after prostate biopsy: Sec. 2, Ch. 10
brain
     dementia with: Sec. 3 Ch. 27 [sidebar]
in thrombocythemia: Sec. 3, Ch. 49
in thrombocytopenia: Sec. 3, Ch. 49; Sec. 3, Ch. 49
vaginal: Sec. 3, Ch. 58
Blepharitis: Sec. 3, Ch. 36
Blepharospasm: Sec. 3, Ch. 30; Sec. 3, Ch. 36
Blind spots
in age-related macular degeneration: Sec. 3, Ch. 36
in diabetes: Sec. 3, Ch. 36
in glaucoma: Sec. 3, Ch. 36
Blindness: Sec. 3, Ch. 36
information resources on: 882-883
Blisters
in shingles: Sec. 3, Ch. 35
Blood clots: Sec. 3, Ch. 49
in abnormal heart rhythms: Sec. 3, Ch. 47
in aneurysm: Sec. 3, Ch. 44; Sec. 3, Ch. 44
in antiphospholipid syndrome: Sec. 3, Ch. 49
in atherosclerosis: Sec. 3, Ch. 44; Sec. 3, Ch. 44
in atrial fibrillation: Sec. 3, Ch. 49
in atrial flutter and fibrillation: Sec. 3, Ch. 47
bed rest and: Sec. 2, Ch. 11; Sec. 3, Ch. 23
in coronary artery disease: Sec. 3, Ch. 45
in deep vein thrombosis: Sec. 3, Ch. 44
in disseminated intravascular coagulation: Sec. 3, Ch. 49; Sec. 3, Ch. 49; Sec. 3, Ch. 49
in heart failure: Sec. 3, Ch. 49
in heart valve disorders: Sec. 3, Ch. 48
in heart: Sec. 3 Ch. 28 [detail]
in hereditary clotting factor disorders: Sec. 3, Ch. 49; Sec. 3, Ch. 49
location of: Sec. 3, Ch. 49
in peripheral arterial disease: Sec. 3, Ch. 44
retinal: Sec. 3, Ch. 36
in stroke: Sec. 3 Ch. 28 [detail]; Sec. 3, Ch. 28; Sec. 3, Ch. 28
in superficial thrombophlebitis: Sec. 3, Ch. 44; Sec. 3, Ch. 44
in thrombocythemia: Sec. 3, Ch. 49
umbrella filter for: Sec. 3, Ch. 44; Sec. 3, Ch. 44
in varicose veins: Sec. 3, Ch. 44
Blood flow: (see Circulation)
Blood pressure
ambulatory monitoring of: Sec. 3, Ch. 43
in heart failure: Sec. 3, Ch. 46
high: (see High blood pressure)
home monitoring of: Sec. 3, Ch. 43
low: (see Low blood pressure)
measurement of: Sec. 3, Ch. 43
control mechanisms of: Sec. 3 Ch. 43 [detail]
in peripheral arterial disease: Sec. 3, Ch. 44
Blood sugar
high: (see Hyperglycemia)
levels of: Sec. 2, Ch. 4
low: (see Hypoglycemia)
monitoring of: Sec. 3, Ch. 34
screening of: Sec. 3, Ch. 34
Blood thinners: (see Anticoagulants)
ginkgo biloba interaction with: Sec. 2, Ch. 7
Blood transfusion
in anemia: Sec. 3, Ch. 49; Sec. 3, Ch. 49
in multiple myeloma: Sec. 3, Ch. 51
in myelofibrosis: Sec. 3, Ch. 49
Blood vessels: Sec. 3, Ch. 44
blood clots in: Sec. 3, Ch. 49
disorders of: Sec. 3, Ch. 44 (see also specific disorders, eg, Atherosclerosis)
small
     blockage in: Sec. 3, Ch. 49
Blood
components of: Sec. 3, Ch. 49
disorders of: Sec. 3, Ch. 49 (see also specific disorders, eg, Anemia)
in gastroesophageal reflux: Sec. 3, Ch. 54
glucose levels in: Sec. 3, Ch. 34; Sec. 3, Ch. 34
hyperviscosity of: Sec. 3, Ch. 51
oxygen content of
     surgery and: Sec. 2, Ch. 12; Sec. 2, Ch. 12
in stool: Sec. 3, Ch. 49
testing of
     in anemia: Sec. 3, Ch. 49
     in benign prostatic hyperplasia: Sec. 3, Ch. 59
     in chronic lymphocytic leukemia: Sec. 3, Ch. 51
     in COPD: Sec. 3, Ch. 53
     in multiple myeloma: Sec. 3, Ch. 51
     in pneumonia: Sec. 3, Ch. 52
     in polycythemia: Sec. 3, Ch. 49
     in thrombocythemia: Sec. 3, Ch. 49
     in thrombocytopenia: Sec. 3, Ch. 49
     in urinary tract infection: Sec. 3, Ch. 56
transfusion of: (see Blood transfusion)
in urine: Sec. 3, Ch. 49
BMI: (see Body mass index)
Board-and-care facility: Sec. 2, Ch. 9; Sec. 2, Ch. 14; Sec. 2, Ch. 14
Body mass index: Sec. 2, Ch. 5; Sec. 2, Ch. 5; Sec. 3, Ch. 17
Bone marrow: Sec. 3, Ch. 49
aging of: Sec. 1, Ch. 2
biopsy of: Sec. 3, Ch. 49
     in anemia: Sec. 3, Ch. 49
     in chronic lymphocytic leukemia: Sec. 3, Ch. 51
     in multiple myeloma: Sec. 3, Ch. 51
     in thrombocythemia: Sec. 3, Ch. 49
     in thrombocytopenia: Sec. 3, Ch. 49
cancer of: (see Leukemia)
fibrosis of: Sec. 3, Ch. 49; Sec. 3, Ch. 49; Sec. 3 Ch. 49 [sidebar]
Bone scan: Sec. 2, Ch. 10
for fracture: Sec. 3, Ch. 23
in lung cancer: Sec. 3, Ch. 51
in prostate cancer: Sec. 3, Ch. 51
Bone spur
in heel: Sec. 3, Ch. 40
Bone(s)
aging of: Sec. 1, Ch. 2
broken: (see Fracture)
density of: Sec. 1, Ch. 2
fracture of: (see Fracture)
healing of: Sec. 3, Ch. 23
in multiple myeloma: Sec. 3, Ch. 51; Sec. 3, Ch. 51; Sec. 3, Ch. 51
in osteoporosis: Sec. 3, Ch. 22
prostate cancer spread to: Sec. 3, Ch. 51
tests on: Sec. 2, Ch. 4; Sec. 2, Ch. 10; Sec. 3, Ch. 22
Botulin toxin
in dystonia: Sec. 3, Ch. 30
Botulinum toxin
in achalasia: Sec. 3, Ch. 54
Bouchard's nodes: Sec. 3, Ch. 41
Bowel ischemia: Sec. 3, Ch. 55
in peripheral arterial disease: Sec. 3, Ch. 44
Bowel movements
abnormal heart rhythms with: Sec. 3, Ch. 47
disorders of: Sec. 3, Ch. 55 (see also Constipation; Diarrhea)
fainting with: Sec. 3 Ch. 20 [sidebar]
at end of life: Sec. 2, Ch. 16
Bowel: (see Large intestine)
BPH: (see Benign prostatic hyperplasia)
Brace
leg or ankle: Sec. 2, Ch. 13
     after stroke: Sec. 2, Ch. 13
Brachytherapy: Sec. 3, Ch. 51
Bradycardia-tachycardia syndrome: Sec. 3, Ch. 47
Bradycardia: Sec. 3, Ch. 47
Braille: Sec. 2, Ch. 13
Brain stem: Sec. 3, Ch. 30
Brain
aging of: Sec. 1, Ch. 1; Sec. 1, Ch. 2
aneurysm in: Sec. 3 Ch. 28 [detail]
arteriovenous malformation of: Sec. 3 Ch. 28 [detail]
blood flow to: Sec. 3, Ch. 20
cancer of
     dementia with: Sec. 3 Ch. 27 [sidebar]
degeneration of
     in Alzheimer's disease: Sec. 3, Ch. 27
     in Parkinson's disease: Sec. 3, Ch. 30
     in progressive supranuclear palsy: Sec. 3, Ch. 30
     in Shy-Drager syndrome: Sec. 3, Ch. 30
in dementia: Sec. 3, Ch. 27 (see also Dementia)
aging of: Sec. 1, Ch. 1
hemorrhage in: Sec. 3 Ch. 28 [detail]; Sec. 3, Ch. 28; Sec. 3, Ch. 28; Sec. 3, Ch. 28
inflammation of (encephalitis): Sec. 3, Ch. 52; Sec. 3, Ch. 52
injury to: (see also Stroke)
in movement disorders: Sec. 3, Ch. 30
radiation injury to: Sec. 3 Ch. 27 [sidebar]
in stroke: (see Stroke)
Bran: Sec. 3, Ch. 55; Sec. 3, Ch. 55
Breasts
aging of: Sec. 1, Ch. 2
biopsy of: Sec. 3, Ch. 51
cancer of
     inflammatory: Sec. 3, Ch. 51
     information resources on: 883
     mammography for: Sec. 2, Ch. 10
     receptors in: Sec. 3, Ch. 51; Sec. 3, Ch. 51; Sec. 2, Ch. 10
     screening for: Sec. 3, Ch. 50; Sec. 3, Ch. 51
     staging of: Sec. 3, Ch. 51
     survival with: Sec. 3, Ch. 51
     treatment of: Sec. 3, Ch. 51
     types of: Sec. 3, Ch. 51
cyst of: Sec. 3, Ch. 51
examination of: Sec. 3, Ch. 51
lump in: Sec. 3, Ch. 51; Sec. 3, Ch. 51
mammography of: Sec. 3, Ch. 51
reconstruction of: Sec. 3, Ch. 51
self-examination of: Sec. 3, Ch. 51
Breath
shortness of
     in aortic regurgitation: Sec. 3, Ch. 48
     in COPD: Sec. 3, Ch. 53; Sec. 3, Ch. 53
     in coronary artery disease: Sec. 3, Ch. 45
     in disseminated intravascular coagulation: Sec. 3, Ch. 49
     in heart attack: Sec. 3 Ch. 45 [sidebar]
     in heart failure: Sec. 3, Ch. 46
     in heart valve disorders: Sec. 3, Ch. 48
     overhydration and: Sec. 3, Ch. 18
     in terminal illness: Sec. 2, Ch. 16
sounds of
     in heart failure: Sec. 3, Ch. 46
Breathing
aging-related changes in: Sec. 1, Ch. 2
bed rest effects on: Sec. 2, Ch. 11
in COPD: Sec. 3, Ch. 53
exercises for: Sec. 3, Ch. 52
near death: Sec. 2 Ch. 16 [sidebar]
after surgery: Sec. 2, Ch. 12
Bretylium: Sec. 3, Ch. 47
Bridge
dental: Sec. 3, Ch. 39
Bright light therapy
in circadian rhythm disorders: Sec. 3, Ch. 31
in seasonal affective disorder: Sec. 3, Ch. 32
Bromocriptine: Sec. 3, Ch. 30; Sec. 3, Ch. 30
Bronchitis
chronic: Sec. 3, Ch. 53
ginkgo biloba in: Sec. 2, Ch. 7
with influenza: Sec. 3, Ch. 52; Sec. 3, Ch. 52
Bronchodilators
in COPD: Sec. 3, Ch. 53
in lung cancer: Sec. 3, Ch. 51
in shortness of breath: Sec. 2, Ch. 16
Bronchoscopy
in pneumonia: Sec. 3, Ch. 52
Bruising
in thrombocytopenia: Sec. 3, Ch. 49
Bulking agents
in constipation: Sec. 3, Ch. 55; Sec. 3, Ch. 55
in diarrhea: Sec. 3, Ch. 55
Bumetanide: Sec. 3, Ch. 18
in heart failure: Sec. 3, Ch. 46; Sec. 3, Ch. 46
Bunion: Sec. 3, Ch. 40
Bupropion
in depression: Sec. 3, Ch. 32; Sec. 3, Ch. 32
for quitting smoking: Sec. 2, Ch. 4
Bursitis
Achilles: Sec. 3, Ch. 40
Buspirone: Sec. 3, Ch. 32
Bypass surgery
in coronary artery disease: Sec. 3, Ch. 45
Contact Merck Site MapPrivacy PolicyTerms of UseCopyright 1995-2008 Merck & Co., Inc.